Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ARIAD Pharmaceuticals Inc (NASDAQ:ARIA)

7.18
Delayed Data
As of Apr 29
 +0.01 / +0.14%
Today’s Change
4.37
Today|||52-Week Range
10.07
+14.88%
Year-to-Date

Today’s Trading

Previous close7.17
Today’s open7.15
Day’s range7.12 - 7.29
Volume2,618,801
Average volume (3 months)3,886,920
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)-41.38%
Earnings growth (this year)+26.02%
Earnings growth (next 5 years)+41.39%
Revenue growth (last year)+12.70%
P/E ratioNM
Price/Sales9.93
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co-0.09-0.28%
LXRXLexicon Pharmaceutic...-0.15-1.07%
FGENFibroGen Inc-0.77-4.10%
DBVTDBV Technologies SA-0.31-0.90%
Data as of 4:00pm ET, 04/29/2016

Financials

Next reporting dateMay 10, 2016
EPS forecast (this quarter)-$0.26
Annual revenue (last year)$118.8M
Annual profit (last year)-$231.2M
Net profit margin-194.57%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Paris Panayiotopoulos
Chief Financial Officer, Treasurer &
Executive VP
Manmeet Singh Soni
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs